The Efficacy of Focused Extracorporeal Shock Wave Therapy and Ultrasound Therapy in the Treatment of Calcar Calcanei: A Randomized Study

• Published in: BioMed research international 2023, Vol.2023 (1), p.8855687-8855687
• Main Authors: Topalovic, Ivana, Nesic, Dejan, Mitrovic, Sindi, Jerkovic, Vera Miler, Konstantinovic, Ljubica
• Format: Article
• Language: English
• Subjects: Calcaneus - diagnostic imaging; Calcification; Calcinosis; Calculi; Care and treatment; Clinical medicine; Comparative analysis; Extracorporeal Shockwave Therapy; Foot diseases; Health aspects; Humans; Lithotripsy; Lower Extremity; Normal distribution; Pain; Patients; Physical therapy; Plantar fasciitis; Prospective Studies; Shock waves; Statistical analysis; Testing; Therapeutics, Physiological; Ultrasonic imaging; Ultrasonic testing; Ultrasonic Therapy; Ultrasonic waves; Ultrasound; X-rays
• ISSN: 2314-6133; 2314-6141
• DOI: 10.1155/2023/8855687

The prospective, simple randomized study assesses the effect of focused extracorporeal shock wave therapy (f-ESWT) on pain intensity and calcification size compared to the application of ultrasound physical therapy in treating patients with calcar calcanei. A total of 124 patients diagnosed with calcar calcanei were consecutively included in the study. The patients were divided into two groups: the experimental group (n=62), which included the patients treated with f-ECWT, and the control group (n=62), consisting of patients treated with the standard ultrasound therapy method. The experimental group’s patients received ten therapy applications spaced seven days apart. The patients in the control group had ten ultrasound treatments on ten consecutive days over two weeks. All patients in both groups were tested using the Visual Analog Scale (VAS) to measure pain intensity before the beginning and at the end of treatment. The size of the calcification was assessed in all patients. The study hypothesizes that f-ESWT reduces the pain and the size of the calcification. Pain intensity reduction was registered in all patients. The calcification size in patients in the experimental group was reduced from the initial range of 2 mm–15 mm, to a content of 0.0 mm–6.2 mm. The calcification size in the control group ranged from 1.2 to 7.5 mm, without any change. None of the patients experienced any adverse reactions to the therapy. Patients treated with standard ultrasound therapy did not have a statistically significant reduction in the calcification size. In contrast, the patients in the experimental group treated with f-ESWT showed a substantial decrease in the calcification size.